Evidence map›Paper›PMID 31597091›Full record

ArticleCell reports2019

Identification of a Paracrine Signaling Mechanism Linking CD34

Márcio Buffolo, Karla Maria Pires, Maroua Ferhat, Olesya Ilkun, Aman Makaju, Alan Achenbach, Faith Bowman, Donald L Atkinson, William L Holland, Ez-Zoubir Amri and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Fate of Adipose Progenitor Cells in Obesity-Related Chronic Inflammation.Frontiers in cell and developmental biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Márcio BuffoloDepartment of Nutrition and Integrative Physiology and Program in Molecular Medicine, University of Utah College of Health, Salt Lake City, UT 84112, USA.
Karla Maria PiresDepartment of Nutrition and Integrative Physiology and Program in Molecular Medicine, University of Utah College of Health, Salt Lake City, UT 84112, USA.
Maroua FerhatDepartment of Nutrition and Integrative Physiology and Program in Molecular Medicine, University of Utah College of Health, Salt Lake City, UT 84112, USA.
Olesya IlkunDepartment of Nutrition and Integrative Physiology and Program in Molecular Medicine, University of Utah College of Health, Salt Lake City, UT 84112, USA.
Aman MakajuNora Eccles Harrison Cardiovascular Research and Training Institute, Salt Lake City, UT 84112, USA.
Alan AchenbachDepartment of Nutrition and Integrative Physiology and Program in Molecular Medicine, University of Utah College of Health, Salt Lake City, UT 84112, USA.
Faith BowmanDepartment of Nutrition and Integrative Physiology and Program in Molecular Medicine, University of Utah College of Health, Salt Lake City, UT 84112, USA.
Donald L AtkinsonDepartment of Nutrition and Integrative Physiology and Program in Molecular Medicine, University of Utah College of Health, Salt Lake City, UT 84112, USA.
William L HollandDepartment of Nutrition and Integrative Physiology and Program in Molecular Medicine, University of Utah College of Health, Salt Lake City, UT 84112, USA.
Ez-Zoubir AmriInstitut de Biologie Valrose, Université Nice Sophia Antipolis, 28, avenue de Valombrose, 06107 Nice Cedex 2, France.
Bhagirath ChaurasiaDepartment of Nutrition and Integrative Physiology and Program in Molecular Medicine, University of Utah College of Health, Salt Lake City, UT 84112, USA.
Sarah FranklinNora Eccles Harrison Cardiovascular Research and Training Institute, Salt Lake City, UT 84112, USA.
Sihem BoudinaDepartment of Nutrition and Integrative Physiology and Program in Molecular Medicine, University of Utah College of Health, Salt Lake City, UT 84112, USA. Electronic address: sihem.boudina@u2m2.utah.edu.
University of Utah · USHarrison Medical Center · USInstitut de Biologie Valrose · FR

Funding

Interdisciplinary Training Program in MetabolismT32DK091317 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI SCOTT A SUMMERS · 2011 to 2026
$4.8M
Novel pathways for fat burning that protects from high fat diet-induced metabolicR01DK098646 · NIDDK · UNIVERSITY OF UTAH · PI BOUDINA, SIHEM · 2013 to 2017
$1.6M
Post-Developmental Adipocyte Autophagy in Control of Insulin-Glucose HomeostasisR01DK100826 · NIDDK · UNIVERSITY OF UTAH · PI BOUDINA, SIHEM · 2013 to 2017
$1.6M
NIDDK NIH HHS R01 DK098646NIDDK NIH HHS R01 DK100826
6 · The paper itself

Abstract

Accumulation of visceral (VIS) is a predictor of metabolic disorders and insulin resistance. This is due in part to the limited capacity of VIS fat to buffer lipids allowing them to deposit in insulin-sensitive tissues. Mechanisms underlying selective hypertrophic growth and tissue remodeling properties of VIS fat are not well understood. We identified subsets of adipose progenitors (APs) unique to VIS fat with differential Cd34 expression and adipogenic capacity. VIS low (Cd34 low) APs are adipogenic, whereas VIS high (Cd34 high) APs are not. Furthermore, VIS high APs inhibit adipogenic differentiation of SUB and VIS low APs in vitro through the secretion of soluble inhibitory factor(s). The number of VIS high APs increased with adipose tissue expansion, and their abundance in vivo caused hypertrophic growth, fibrosis, inflammation, and metabolic dysfunction. This study unveils the presence of APs unique to VIS fat involved in the paracrine regulation of adipogenesis and tissue remodeling.

Indexed as

Paracrine CommunicationSignal TransductionAdipogenesisAdipose Tissue, WhiteAnimalsAntigens, CD34Bone Morphogenetic Protein 4FibroblastsInsulin ResistanceIntra-Abdominal FatMaleMice, Inbred C57BLMuscle, SmoothPhenotypeRosiglitazoneSolubilityAntigens, CD34Bone Morphogenetic Protein 4Rosiglitazoneadipose progenitorscell sortingfat expansiontransplantationvisceral fat

Identifiers

PMID31597091
PMCPMC10950319
OpenAlexW2979621944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.